Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

TriLink Awards Keck Science Department Research Reward

Published: Monday, March 11, 2013
Last Updated: Monday, March 11, 2013
Bookmark and Share
Company has granted research reward to Dr. Aaron Leconte for mutant polymerase research.

TriLink BioTechnologies Inc. has granted Dr. Aaron Leconte of the WM Keck Science Department of Claremont McKenna, Pitzer and Scripps Colleges a Research Reward for mutant polymerase research.

"The use of DNA biotechnologies is often limited by which DNA polymerases recognize which modified nucleotide analogs," stated Dr. Leconte.

"In my lab, we are working on discovering DNA polymerases with novel substrate recognition to expand the usefulness of modified nucleotides. TriLink is one of the leaders in the synthesis of high-quality, novel nucleotide analogs, and this Research Rewards grant enables us to work on a significantly more diverse set of nucleotide analogs," concluded Dr. Leconte.

"We are pleased that TriLink's modified nucleotide analogs and custom oligonucleotides help advance directed enzyme evolution." commented Richard Hogrefe, CEO of TriLink.

Hogrefe continued, "TriLink continues to expand its portfolio of nucleotide analogs to support researchers like Dr. Leconte, as they push the envelope of science."

TriLink has been proud to support research and education with its Research Reward Program, since the program's inception in 2002.

Over 35 grants have been awarded for research including nucleotide selectivity of error prone RNA viral polymerases, PCR primer design for undergraduate teaching and research, CleanAmp™ Primers for detection of mRNA expression and DNA repair studies of cross-linked DNA.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos